Brief: Spago Nanomedical Focuses Resources On Development Of Tumorad
Oct 1 (Reuters) - Spago Nanomedical AB (publ)
SPAGO.ST :
* RESOURCES WILL BE FOCUSED ON DEVELOPMENT OF TUMORAD
* ORGANIZATIONAL CHANGES WILL BE MADE
* FOCUS ON TUMORAD PROGRAM RESULTS IN THAT INTERNAL
PRECLINICAL
DISCOVERY ACTIVITIES WILL CEASE
* THIS IS EXPECTED TO LEAD TO SIGNIFICANTLY REDUCED COSTS
* MEASURES DECIDED ON INCLUDE STAFF REDUCTIONS
Source text for Eikon: ID:nMFN5Hz3Hh
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose